Skip to main content
Top
Published in: Journal of General Internal Medicine 7/2021

01-07-2021 | Care | Original Research

Understanding Experiences of Moral Distress in End-of-Life Care Among US and UK Physician Trainees: a Comparative Qualitative Study

Authors: Sarah Rosenwohl-Mack, MD, MPH, Daniel Dohan, PhD, Thea Matthews, BA, Jason Neil Batten, MD, Elizabeth Dzeng, MD, MPH, PhD

Published in: Journal of General Internal Medicine | Issue 7/2021

Login to get access

Abstract

Background

Moral distress is a state in which a clinician cannot act in accordance with their ethical beliefs because of external constraints. Physician trainees, who work within rigid hierarchies and who lack clinical experience, are particularly vulnerable to moral distress. We examined the dynamics of physician trainee moral distress in end-of-life care by comparing experiences in two different national cultures and healthcare systems.

Objective

We investigated cultural factors in the US and the UK that may produce moral distress within their respective healthcare systems, as well as how these factors shape experiences of moral distress among physician trainees.

Design

Semi-structured in-depth qualitative interviews about experiences of end-of-life care and moral distress.

Participants

Sixteen internal medicine residents in the US and fourteen junior doctors in the UK.

Approach

The work was analyzed using thematic analysis.

Key Results

Some drivers of moral distress were similar among US and UK trainees, including delivery of potentially inappropriate treatments, a poorly defined care trajectory, and involvement of multiple teams creating different care expectations. For UK trainees, healthcare team hierarchy was common, whereas for US trainees, pressure from families, a lack of guidelines for withholding inappropriate treatments, and distress around physically harming patients were frequently cited. US trainees described how patient autonomy and a fear of lawsuits contributed to moral distress, whereas UK trainees described how societal expectations around resource allocation mitigated it.

Conclusion

This research highlights how the differing experiences of moral distress among US and UK physician trainees are influenced by their countries’ healthcare cultures. This research illustrates how experiences of moral distress reflect the broader culture in which it occurs and suggests how trainees may be particularly vulnerable to it. Clinicians and healthcare leaders in both countries can learn from each other about policies and practices that might decrease the moral distress trainees experience.
Literature
19.
go back to reference Beauchamp TL, Childress JF. Principles of Biomedical Ethics. 7. Oxford University Press; Oxford 2012. Beauchamp TL, Childress JF. Principles of Biomedical Ethics. 7. Oxford University Press; Oxford 2012.
23.
go back to reference Winkenwerder W. Ethical Dilemmas for House Staff Physicians. J Am Med Assoc 1985;254(24):3454-3457.CrossRef Winkenwerder W. Ethical Dilemmas for House Staff Physicians. J Am Med Assoc 1985;254(24):3454-3457.CrossRef
30.
52.
go back to reference Starr P. The social transformation of American medicine: The rise of a sovereign profession and the making of a vast industry. New York. Basic Books; 1982. Starr P. The social transformation of American medicine: The rise of a sovereign profession and the making of a vast industry. New York. Basic Books; 1982.
Metadata
Title
Understanding Experiences of Moral Distress in End-of-Life Care Among US and UK Physician Trainees: a Comparative Qualitative Study
Authors
Sarah Rosenwohl-Mack, MD, MPH
Daniel Dohan, PhD
Thea Matthews, BA
Jason Neil Batten, MD
Elizabeth Dzeng, MD, MPH, PhD
Publication date
01-07-2021
Publisher
Springer International Publishing
Keyword
Care
Published in
Journal of General Internal Medicine / Issue 7/2021
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-06314-y

Other articles of this Issue 7/2021

Journal of General Internal Medicine 7/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.